Financials ProstaLund AB

Equities

PLUN

SE0002372318

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Stockholm 11:17:25 2024-05-29 EDT 5-day change 1st Jan Change
0.578 SEK -0.34% Intraday chart for ProstaLund AB +2.48% -64.54%

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 85.61 105.4 112.6 213.3 228.5 124.8
Enterprise Value (EV) 1 83.53 96.02 102.7 200.3 217.9 110.8
P/E ratio -6.31 x -7.04 x -9.89 x -24.4 x -19 x -6.52 x
Yield - - - - - -
Capitalization / Revenue 6.31 x 8.18 x 9.03 x 12.5 x 13.1 x 5.62 x
EV / Revenue 6.16 x 7.45 x 8.24 x 11.7 x 12.5 x 4.99 x
EV / EBITDA -6.56 x -9.25 x -10.4 x -25.8 x -20.2 x -8.74 x
EV / FCF -12.8 x -10.8 x -12.2 x -16.8 x -13.9 x -6.07 x
FCF Yield -7.82% -9.28% -8.2% -5.94% -7.19% -16.5%
Price to Book 6.74 x 4.74 x 4.44 x 6.02 x 5.48 x 2.26 x
Nbr of stocks (in thousands) 13,698 32,525 42,157 51,525 57,193 76,589
Reference price 2 6.250 3.240 2.670 4.140 3.995 1.630
Announcement Date 19-04-09 20-03-27 21-04-06 22-04-11 23-04-04 24-04-19
1SEK in Million2SEK
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 13.57 12.89 12.46 17.07 17.41 22.21
EBITDA 1 -12.74 -10.38 -9.877 -7.755 -10.76 -12.68
EBIT 1 -12.95 -10.44 -9.919 -7.855 -10.89 -12.85
Operating Margin -95.45% -81% -79.57% -46.01% -62.56% -57.87%
Earnings before Tax (EBT) 1 -12.95 -10.58 -9.98 -7.884 -11.1 -17.01
Net income 1 -12.95 -10.58 -9.98 -7.884 -11.1 -17.01
Net margin -95.45% -82.13% -80.06% -46.18% -63.74% -76.6%
EPS 2 -0.9900 -0.4600 -0.2700 -0.1700 -0.2100 -0.2500
Free Cash Flow 1 -6.535 -8.912 -8.422 -11.89 -15.66 -18.27
FCF margin -48.17% -69.16% -67.56% -69.65% -89.97% -82.28%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 19-04-09 20-03-27 21-04-06 22-04-11 23-04-04 24-04-19
1SEK in Million2SEK
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 2.09 9.36 9.9 13 10.5 14
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 -6.54 -8.91 -8.42 -11.9 -15.7 -18.3
ROE (net income / shareholders' equity) -97.8% -60.6% -41.9% -25.9% -28.8% -35.1%
ROA (Net income/ Total Assets) -43.7% -28.6% -21.7% -13.2% -14.4% -13.8%
Assets 1 29.66 36.94 46.06 59.67 77.04 123.4
Book Value Per Share 2 0.9300 0.6800 0.6000 0.6900 0.7300 0.7200
Cash Flow per Share 2 0.2100 0.3000 0.2500 0.2600 0.2100 0.2000
Capex 1 0.01 - 0.31 0.2 0.15 0.15
Capex / Sales 0.04% - 2.45% 1.14% 0.84% 0.66%
Announcement Date 19-04-09 20-03-27 21-04-06 22-04-11 23-04-04 24-04-19
1SEK in Million2SEK
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. PLUN Stock
  4. Financials ProstaLund AB